Markman Capital Insight

Why Oracle Will Survive And Thrive In Tech Shake-Out

To learn how to improve your results in the market dramatically by buying options on stocks like Ford and Tesla, take a two-week trial to my special service, Tactical Options: Click here. Members have made more than 5x their money this year.

Investors are buying up legacy companies as quickly as they are dumping innovative digital businesses. Everything is upside down. It may stay that way for a while.

Shares of HewlettHPQ Packard (HPQ) jumped last week to a new high as DocuSign (DOCU) stock plummeted. Luddite investors are choosing printers and messy ink over the digital equivalent.

It’s time to consider buying OracleORCL Systems (ORCL). Let me explain.

The stock market is in the midst of a rotation. It is the beginning of the year and the really big money is pouring into the market. Large institutional accounts skew heavily toward conservative, value investing strategies. This makes sense. Their investors, mostly pension funds, are more afraid of losing their capital than posting big returns.

Holding Hewlett Packard in the portfolio is an easier sell to clients than DocuSign. Hewlett is a fundamentally cheap household name whereas DocuSign is a cloud-based software platform for signing documents virtually. It’s also relatively expensive and unfamiliar.

The other variable is rising interest rates.

Institutional Investor notes that value investors blame the Federal Reserve and a decade of low interest rates for their poor performance relative to their growth contemporaries. Value managers also claim that higher interest rates will negatively impact growth stock valuations. In the short term this narrative can drive stock prices.

The yield of the 10-year Treasury bond rose last week to 1.76%, up from only 1.3% a month ago. Using S&P Value ETF (IVX) and S&P Growth ETF (IGX) as benchmarks, during the past 30 days value is up 4%, while growth is down 3.8%.

However, over time frames longer than a quarter or two, investors would have been better off choosing growth over value strategies, regardless if rates were rising or falling.

Growth beat value by 28% from the pandemic lows in 2020 through last week, even as rates have risen sharply. The margin widens to 105% over the past five years, and 258% over 20 years. Regardless how often it repeated in the financial press, the inflection point for growth vs. value strategies is not the trend for interest rates.

Value strategies perform best the beginning of each calendar year when institutional money inflows are the highest.

It makes perfect sense that Hewlett shares have been stronger. At $38.65 the stock trades at only 8.3x forward earnings. The dividend is 2.0% and the gross operating margin is 21.1%, an extremely respectable rate many value investors have noticed.

However, it is wrong to dismiss DocuSign outright. Although the company is not yet profitable, sales grew to $545 million in the third quarter, an increase of 42% year-over-year. Gross operating margins moved up to 79%, 500 basis points higher than a year ago.

Oracle Systems is the perfect compromise.

The company is the global leader in database management systems. Its software helps large clients wring out useful information from large pools of information. Given the scale of that business Oracle has become a cash cow, allowing executives to return capital to shareholders at breakneck pace.

The company bought back 329 million shares in the last year alone, spending $21 billion. Dividends accounted for another $3 billion.     

The database giant is growing briskly in the cloud, too. Unlike competitors, its portfolio includes applications, platform and infrastructure services. The company reported in December that second quarter sales reached $10.4 billion, up 6% year-over-year. Total cloud revenue surged 22%, to $2.7 billion.

Shares have come under pressure since December 16 when executives announced the $28.3 billion purchase of CernerCERN Corp. (CERN), a digital medical records business.

In the current climate, where investors are swapping growth for value stocks, the weakness is an opportunity value investor are certain to notice.

For many decades Oracle has been the quintessential growth stock, fundamentally too expensive of value investors. At $87.51 shares now trade at only 16.6x forward earnings and company leaders claim that the Cerner acquisition will be accretive. The dividend yield is 1.3% and gross operating margins are remarkable at 80%.

Longer-term investors should consider buying Oracle shares into the current pullback.